The activated chimeric BCR-ABL tyrosine kinase is the key biochemical defect that causes Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) [40]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.